Study of proton relaxation in articular tissues following trauma according to nuclear magnetic resonance data
Rokitianskiĭ, V.I.; Iakimov, I.V.
Ortopediia Travmatologiia i Protezirovanie 32(9): 35-41
1971
ISSN/ISBN: 0030-5987 PMID: 5138723 Document Number: 40792
Document emailed within 1 workday
Related Documents
Nadal, L.; Leray, G.; Desbarats, C.; Darcel, F.; Bansard, J.Y.; Bondon, A.; de Certaines, J.D. 1997: Proton and phosphorus nuclear magnetic resonance spectroscopy of human brain tumor extracts with automatic data classification: a preliminary study Cellular and Molecular Biology 43(5): 659-673Ling, G.N.; Tucker, M. 1980: Nuclear magnetic resonance relaxation and water contents in normal mouse and rat tissues and in cancer cells Journal of the National Cancer Institute 64(5): 1199-1207
Mori, K.; Terubayashi, H.; Akagi, Y.; Okamoto, S.; Tsutsumi, M.; Ikebe, H.; Yoshizaki, K.; Nishikawa, H. 1991: Quantitative study of rat diabetic cataract, by the relaxation times of nuclear magnetic resonance Nippon Ganka Gakkai Zasshi 95(4): 336-342
Outhred, R.K.; George, E.P. 1973: A nuclear magnetic resonance study of hydrated systems using the frequency dependence of the relaxation processes Biopolymers 13(2): 83-96
Klimek, R.; Lauterbur, P.C.; Mendoça Dias, M.H. 1981: A discussion of nuclear magnetic resonance (NMR) relaxation time of tumors in terms of their interpretation as self-organizing dissipative structures, and of their study in vivo by NMR zeugmatographic imaging Ginekologia Polska 52(6): 493-502
Ong, R.L.; Pittman, C.S. 1985: Proton nuclear magnetic resonance assignments of thyroid hormone and its analogues Biochemistry International 10(5): 803-811
Mountford, C.E.; Grossman, G.; Reid, G.; Fox, R.M. 1982: Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy Cancer Research 42(6): 2270-2276
Bakunovich, A.V.; Sinitsyn, V.E.; Mershina, E.A. 2014: Clinical use of proton magnetic resonance spectroscopy in brain tumors and adjacent tissues Vestnik Rentgenologii i Radiologii 1: 39-50
Zhang, C.-Y.; Zhang, N.; He, L. 2014: Quantitative determination of bosentan by proton nuclear magnetic resonance with internal standard method Yao Xue Xue Bao 49(2): 249-251
Stewart, R.G.; Runge, V.M.; Brenner, D.E.; Witt, W.S.; Partain, C.L.; James, A.E. 1984: Nuclear magnetic resonance relaxation rates of serum from lung cancer patients: work in progress Journal of the Tennessee Medical Association 77(3): 131-133
de Certaines, J.D.; Nadal, L.; Leray, G.; Serrai, H.; Lewa, C.J. 1996: Proton nuclear magnetic resonance spectroscopy of plasma lipoprotein: technical problems and potential interest in cancer disease Anticancer Research 16(3b): 1451-1460
Hanna, G.M. 1995: Determination of ephedrine, pseudoephedrine, and norephedrine in mixtures (bulk and dosage forms) by proton nuclear magnetic resonance spectroscopy Journal - Association of Official Analytical Chemists 78(4): 946-954
Van Echteld, C.J.; Meijler, F.L. 1986: Nuclear magnetic resonance spectroscopy in medicine: biochemistry of intact tissues Nederlands Tijdschrift Voor Geneeskunde 130(36): 1595-1602
Ranade, S.S.; Chaughule, R.S.; Kasturi, S.R.; Nadkarni, J.S.; Talwalkar, G.V.; Wagh, U.V.; Korgaonkar, K.S.; Vijayaraghavan, R. 1975: Pulsed nuclear magnetic resonance studies on human malignant tissues and cells in vitro Indian Journal of Biochemistry and Biophysics 12(3): 229-232
Lorenz, R.; Hedde, J.P.; Diehl, V. 1993: Can nuclear magnetic resonance tomography supplement and expand splenic diagnosis in malignant systemic diseases? Comparison of nuclear magnetic resonance tomography, ultrasound and computerized tomography findings Medizinische Klinik 88(3): 125-128
Roberts, D.W. 1992: The use of proton nuclear magnetic resonance spectrometry (1H NMR) for monitoring the reaction of epoxides with butylamine and predictive capabilities of the relative alkylation index (RAI) for skin sensitization by epoxides Toxicology and Applied Pharmacology 112(2): 331-332
Grand, R.J.; Levine, B.A.; Byrd, P.J.; Gallimore, P.H. 1989: The binding of guanine nucleotide to N-ras p21--a phosphorous and proton magnetic resonance study Oncogene 4(3): 355-361
Fiegler, W.; Felix, R.; Schörner, W.; Köhler, D. 1985: Diagnosis of kidney diseases with magnetic resonance tomography including the use of nuclear magnetic resonance contrast media Der Urologe. Ausg. a 24(5): 264-269
Rumbach, L.; Caires, M.C.; Warter, J.M.; Collard, M.; Scheiber, C.; Gounot, D.; Dumitresco, B.; Chambron, J. 1985: Contribution to proton nuclear magnetic resonance imaging in multiple sclerosis. Contribution of a multiple spin echo sequence Revue Neurologique (Paris) 141(8-9): 583-586
Szulc, A.; Galińiska, B.; Tarasów, E.; Dzienis, W.; Kubas, B.; Konarzewska, B.; Waszkiewicz, N.; Popławska, R. 2010: The influence of atypical antipsychotics on brain functioning in schizophrenia. a proton magnetic resonance study Psychiatria Polska 44(3): 415-426